Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 05 2023
Historique:
received: 20 10 2022
accepted: 27 04 2023
medline: 31 5 2023
pubmed: 30 5 2023
entrez: 29 5 2023
Statut: epublish

Résumé

Highly pathogenic avian influenza A(H5N1) viruses of clade 2.3.4.4b underwent an explosive geographic expansion in 2021 among wild birds and domestic poultry across Asia, Europe, and Africa. By the end of 2021, 2.3.4.4b viruses were detected in North America, signifying further intercontinental spread. Here we show that the western movement of clade 2.3.4.4b was quickly followed by reassortment with viruses circulating in wild birds in North America, resulting in the acquisition of different combinations of ribonucleoprotein genes. These reassortant A(H5N1) viruses are genotypically and phenotypically diverse, with many causing severe disease with dramatic neurologic involvement in mammals. The proclivity of the current A(H5N1) 2.3.4.4b virus lineage to reassort and target the central nervous system warrants concerted planning to combat the spread and evolution of the virus within the continent and to mitigate the impact of a potential influenza pandemic that could originate from similar A(H5N1) reassortants.

Identifiants

pubmed: 37248261
doi: 10.1038/s41467-023-38415-7
pii: 10.1038/s41467-023-38415-7
pmc: PMC10227026
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

3082

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400006C
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93021C00016
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150745
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

mBio. 2022 Aug 30;13(4):e0060922
pubmed: 35726917
Virology. 1983 Jun;127(2):361-73
pubmed: 6868370
Emerg Infect Dis. 2023 Apr;29(4):786-791
pubmed: 36958010
Anal Biochem. 1979 Apr 15;94(2):287-96
pubmed: 464297
China CDC Wkly. 2021 Sep 03;3(36):751-756
pubmed: 34594983
Science. 2012 Jun 22;336(6088):1534-41
pubmed: 22723413
Influenza Other Respir Viruses. 2015 Sep;9(5):271-6
pubmed: 25966311
J Virol. 2010 Feb;84(3):1527-35
pubmed: 19923184
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11044-9
pubmed: 20534457
Viruses. 2021 Apr 24;13(5):
pubmed: 33923198
Science. 2022 Apr 29;376(6592):459-460
pubmed: 35471045
mBio. 2018 Apr 24;9(2):
pubmed: 29691337
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Emerg Infect Dis. 2022 May;28(5):1006-1011
pubmed: 35302933
J Virol. 1984 May;50(2):654-6
pubmed: 6708174
Antiviral Res. 2022 Apr;200:105281
pubmed: 35292289
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
J Virol Methods. 2014 Dec 15;210:7-14
pubmed: 25233882
J Virol. 2013 May;87(9):4826-34
pubmed: 23449784
Virus Genes. 2019 Dec;55(6):739-768
pubmed: 31428925
J Virol. 2009 Apr;83(8):3568-80
pubmed: 19193808
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1636-41
pubmed: 26811446
J Open Source Softw. 2021;6(57):
pubmed: 34189396
J Virol Methods. 1989 Apr-May;24(1-2):27-34
pubmed: 2760163
Nature. 1983 May 5-11;303(5912):41-4
pubmed: 6188957
J Virol. 2009 Oct;83(19):10309-13
pubmed: 19605485
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8593-8601
pubmed: 32217734
Vaccine. 2002 Aug 19;20(25-26):3165-70
pubmed: 12163268
PLoS Pathog. 2021 Sep 3;17(9):e1009910
pubmed: 34478484
Emerg Infect Dis. 2022 Sep;28(9):1913-1915
pubmed: 35840125
PLoS Med. 2007 Feb;4(2):e59
pubmed: 17298168
Sci Rep. 2022 Jul 11;12(1):11729
pubmed: 35821511
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9033-8
pubmed: 27457948
Int J Mol Sci. 2017 Dec 13;18(12):
pubmed: 29236050
Nature. 2012 May 02;486(7403):420-8
pubmed: 22722205
Euro Surveill. 2023 Jan;28(3):
pubmed: 36695488
mSphere. 2016 Apr 06;1(2):
pubmed: 27303732

Auteurs

Ahmed Kandeil (A)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza, 12622, Egypt.

Christopher Patton (C)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, 38105, USA.

Jeremy C Jones (JC)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Trushar Jeevan (T)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Walter N Harrington (WN)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Sanja Trifkovic (S)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Jon P Seiler (JP)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Thomas Fabrizio (T)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Karlie Woodard (K)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Jasmine C Turner (JC)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Jeri-Carol Crumpton (JC)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Lance Miller (L)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Adam Rubrum (A)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Jennifer DeBeauchamp (J)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Charles J Russell (CJ)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Elena A Govorkova (EA)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Peter Vogel (P)

Comparative Pathology Core, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Mia Kim-Torchetti (M)

National Veterinary Services Laboratories, Animal and Plant Health Inspection Service (APHIS), US Department of Agriculture (USDA), Ames, IA, 50011, USA.

Yohannes Berhane (Y)

National Centre for Foreign Animal Disease, Winnipeg, MB, R3E 3M4, Canada.
Department of Animal Science, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.

David Stallknecht (D)

Southeastern Cooperative Wildlife Disease Study, Department of Population Health, College of Veterinary Medicine, The University of Georgia, Athens, GA, 30602, USA.

Rebecca Poulson (R)

Southeastern Cooperative Wildlife Disease Study, Department of Population Health, College of Veterinary Medicine, The University of Georgia, Athens, GA, 30602, USA.

Lisa Kercher (L)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.

Richard J Webby (RJ)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA. richard.webby@stjude.org.
Department of Microbiology, Immunology, and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, 38105, USA. richard.webby@stjude.org.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH